Skip to main content

Table 1 Characteristics of Patients Who Received Fluticason Propionate (FP) and Beclomethason Dipropionate (BDP) at the Beginning of the Study

From: Comparison of Effectiveness between Beclomethasone Dipropionate and Fluticasone Propionate in Treatment of Children with Moderate Asthma

 

FP

BDP

P Value

Number of studied patients

25

25

--

Male/female

12/13

15/10

0.39

Age; year (mean ± SD)

11.25 ± 4.3

12.8 ± 4.4

0.72

FEV1 (mean ± SD)

71.68 ± 5.76

69.48 ± 4.69

0.155

FVC (mean ± SD)

79.72 ± 7.61

72.60 ± 7.33

0.179

FEV1/FVC (mean ± SD)

0.74 ± 0.05

0.73 ± 0.04

0.852

FEF25-75 (mean ± SD)

49.6 ± 6.09

47.32 ± 6.34

0.201

Night symptoms*

6.32 ± 1.22

6.28 ± 1.24

0.880

Daily symptoms†

2.60 ± 1.16

2.80 ± 1.16

0.522

  1. *Night problems per month. †Wheezing or cough per week need bronchodilator.
Back to article page

World Allergy Organization Journal

ISSN: 1939-4551

Contact us